PLx Pharma
Financial ratios & Valuation

Historical Multiples (2013 – 2021)

2013 2014 2015 2016 2017 2018 2019 2020 2021 TTM Median
Valuation Ratios
Price/Earnings ratio
-16.17-6.58-5.63-0.77-3.1514.90-1.82-3.55-3.68-0.12-1.96
Price/Sales ratio
N/AN/AN/AN/A62.2017.7468.901.76K23.070.7539.97
Price/Book Value ratio
20.243.443.421.1010.492.0724.825.133.660.136.28
Price/Cash Flow ratio
-29.58-7.92-7.23-1.06-3.63-1.40-3.07-4.37-5.89-0.05-2.35
Price/Free Cash Flow ratio
-29.58-7.92-7.23-1.06-3.49-1.31-3.02-4.34-5.89-0.05-2.28
Price/Earnings Growth ratio
0.17-0.06-0.37-0.220.03-0.140.000.10-0.09-0.11-0.05
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/A100%100%100%100%41.45%4.45%100%
Operating Profit Margin
N/AN/AN/AN/A-2035.27%-1455.45%-2511.61%-44229.74%-496.95%-1417.83%-1726.55%
Pretax Profit Margin
N/AN/AN/AN/A-2089.07%119.03%-3625.76%-49985.71%-561.95%-606.91%-1347.99%
Net Profit Margin
N/AN/AN/AN/A-1970.92%119.03%-3773.73%-49631.90%-626.94%-606.91%-1288.91%
Effective Tax Rate
N/AN/AN/AN/A5.65%1450.49%-4.08%0.70%-11.56%N/A728.07%
Return on Assets
-99.59%-49.91%-57.83%-124.75%-53.19%4.87%-115.32%-56.74%-67.14%-83.00%-24.16%
Return On Equity
-125.18%-52.33%-60.84%-142.43%-332.43%13.91%-1359.51%-144.48%-99.57%-72.39%-237.43%
Return on Capital Employed
-125.18%-52.33%-60.92%-142.74%-58.62%-80.26%-114.44%-58.32%-62.98%-239.39%-69.44%
Liquidity Ratios
Current Ratio
N/A21.5420.148.0214.143.142.346.48N/A4.789.46
Quick Ratio
4.6821.5420.148.0214.013.142.346.445.974.119.06
Cash ratio
4.6821.453.257.8513.443.012.296.335.844.098.76
Days of Sales Outstanding
N/AN/AN/AN/A9.088.8312.05N/A28.1911.1610.12
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/A186.71267.19N/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/A214.90269.94N/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/AN/A805.20426.18N/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/A-590.29-349.13N/A
Debt Ratios
Debt Ratio
0.20N/AN/AN/A0.240.390.230.02N/A0.210.31
Debt Equity Ratio
N/AN/AN/AN/A1.501.112.720.05N/A0.261.30
Long-term Debt to Capitalization
N/AN/AN/AN/A0.600.390.28N/AN/AN/A0.49
Total Debt to Capitalization
N/AN/AN/AN/A0.600.520.730.05N/AN/A0.56
Interest Coverage Ratio
N/AN/AN/AN/A-11.63-9.56-14.27-43.70N/A-426.65-10.60
Cash Flow to Debt Ratio
N/AN/AN/AN/A-1.91-1.32-2.95-19.67N/AN/A-0.95
Company Equity Multiplier
1.251.041.051.146.242.8511.782.541.481.264.55
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/A-17.08-12.61-22.38-402.35-3.91-13.05-15.07
Free Cash Flow / Operating Cash Flow Ratio
11111.041.061.011.00111.05
Cash Flow Coverage Ratio
N/AN/AN/AN/A-1.91-1.32-2.95-19.67N/AN/A-0.95
Short Term Coverage Ratio
N/AN/AN/AN/AN/A-3.26-3.46-19.67N/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A